Pi-Cardia
ShortCut Device Used to Treat a Patient Reported a Success
ShortCut is the world’s first dedicated device designed to split the leaflets of a pre-existing valve to enable safe Transcatheter Aortic Valve Replacement in patients at risk for coronary obstruction or compromised coronary access.
Venus Medtech to Partner with Pi-Cardia to Bring its Leaflex™ Aortic Valve Technology to China
Pi-Cardia's Leaflex™ catheter performs mechanical scoring of valve calcification, restoring leaflets' mobility and improving valve hemodynamics.